A case of conventional treatment failure in visceral leishmaniasis: leukocyte distribution and cytokine expression in splenic compartments

BMC Infect Dis. 2014 Sep 9:14:491. doi: 10.1186/1471-2334-14-491.

Abstract

Background: In this paper we study the distribution of leukocyte populations and of cytokine-producing cells in the spleen of a patient with visceral leishmaniasis resistant to clinical treatment. It is the first attempt to compare the distribution of leukocyte populations and cytokine-producing cells in the splenic compartments of a patient with visceral leishmaniasis with those observed in patients without the disease.

Case presentation: A 25-year-old male, farmer, was hospitalized on several occasions with diagnosis of visceral leishmaniasis and received all recommended treatments for the disease with only transient improvement followed by relapse. He was eventually subjected to splenectomy in order to control the effects of hypersplenism and to potentially overcome infection. After surgery and combined chemotherapy, the disease evolved to cure. In comparison with the spleens of the other two patients without visceral leishmaniasis, an increase was observed in the CD4/CD8 ratio and in the number of IL-10- and FoxP3-producing cells, while the number of IL-17-producing cells was lower in the spleen of the patient with visceral leishmaniasis.

Conclusion: This report confirms previous data on changes in the CD4/CD8 ratio in the spleens of patients with visceral leishmaniasis. Additionally the data presented herein suggests that splenic FoxP3- and IL-17-producing cells are involved in the chronicity of visceral leishmaniasis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cytokines / genetics*
  • Cytokines / immunology
  • Humans
  • Leishmania infantum / physiology
  • Leishmaniasis, Visceral / drug therapy
  • Leishmaniasis, Visceral / genetics
  • Leishmaniasis, Visceral / immunology
  • Leishmaniasis, Visceral / therapy*
  • Leukocyte Count
  • Leukocytes / cytology*
  • Leukocytes / immunology
  • Male
  • Middle Aged
  • Spleen / cytology
  • Spleen / immunology*
  • Treatment Failure

Substances

  • Cytokines